3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Interventions
vandetanib
9
cabozantinib
6
selpercatinib
4
Sorafenib
3
Sunitinib
2
Magnetic Resonance Spectroscopy
2
yeast-CEA vaccine
1
tanespimycin
1
rovalpituzumab tesirine
1
pralsetinib
1
pembrolizumab
1
pazopanib
1
lenvatinib
1
Vorinostat
1
Temozolomide
1
Specimen Handling
1
Pharmacogenomic Testing
1
Nivolumab
1
Lithium Carbonate
1
Irinotecan
1
Gefitinib
1
Ferrosoferric Oxide
1
Dexamethasone
1
Capecitabine
1
Bortezomib
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Medullary
×
Absorptiometry, Photon
×
Clear all
No trials found.